Advertisement
Advertisement

LNSR

LNSR logo

LENSAR, Inc. Common Stock

5.64
USD
Sponsored
+0.41
+7.84%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

5.64

0.00
0.00%

LNSR Earnings Reports

Positive Surprise Ratio

LNSR beat 9 of 22 last estimates.

41%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$15.30M
/
-$0.20
Implied change from Q1 26 (Revenue/ EPS)
+13.92%
/
--
Implied change from Q2 25 (Revenue/ EPS)
+9.80%
/
+33.33%

LENSAR, Inc. Common Stock earnings per share and revenue

On May 08, 2026, LNSR reported earnings of 0.00 USD per share (EPS) for Q1 26, missing the estimate of 0.18 USD, resulting in a -100.00% surprise. Revenue reached 13.43 million, compared to an expected 13.72 million, with a -2.11% difference. The market reacted with a +7.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.20 USD, with revenue projected to reach 15.30 million USD, implying an -- of --% EPS, and increase of 13.92% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Artivion, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.05
Actual
$0.08
Surprise
+59.68%
logo
Tandem Diabetes Care, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.45
Actual
-$0.30
Surprise
+34.01%
logo
Pacific Biosciences of California, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.73%
logo
Delcath Systems Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.03
Surprise
+66.06%
logo
EDAP TMS SA
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.19
Actual
-$0.24
Surprise
-25.59%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.28
Surprise
+10.88%
logo
Sensus Healthcare, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.16
Surprise
-25.49%
logo
Mettler-Toledo International
Report Date
May 07, 2026 For Q1 26
Estimate
$8.78
Actual
$8.91
Surprise
+1.37%
logo
GLOBUS MEDICAL INC
Report Date
May 07, 2026 For Q1 26
Estimate
$0.93
Actual
$1.12
Surprise
+19.39%
logo
Teleflex Incorporated
Report Date
May 07, 2026 For Q1 26
Estimate
$1.22
Actual
$1.39
Surprise
+13.68%
FAQ
For Q1 2026, LENSAR, Inc. Common Stock reported EPS of $0.00, missing estimates by -100%, and revenue of $13.43M, -2.11% below expectations.
The stock price moved up 7.84%, changed from $5.23 before the earnings release to $5.64 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 3 analysts, LENSAR, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $15.30M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement